对于帕金森病自身干细胞移植的进展
1Department of Neurology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Current stem cell research & therapy
|September 11, 2023
概括
自主干细胞移植为帕金森病 (PD) 提供了一种有前途的再生方法,有可能阻止神经退行,与目前的疗法不同. 本综述检查了其安全性,有效性和优势,而不是 PD 治疗的异构移植.
科学领域:
- 神经科学是一个神经科学.
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
背景情况:
- 帕金森病 (PD) 涉及多巴胺基神经元的渐进性神经退行,导致运动和非运动症状.
- 目前的治疗方法,如药物治疗和深度大脑刺激 (DBS),可以控制症状,但不能阻止疾病的进展.
- 干细胞疗法提出了一种再生策略,以解决PD的潜在病理.
研究的目的:
- 审查对帕金森病自身干细胞移植的安全性和有效性.
- 为了比较自身与异性干细胞移植在PD中的好处.
- 讨论评估PD干细胞程序有效性的方法.
主要方法:
- 对PD自身干细胞移植的临床前和临床研究的综述.
- 讨论安全问题,包括瘤性和移植并发症.
- 分析用于评估干细胞疗法的疗效的方法.
主要成果:
- 自主干细胞移植显示,由于其再生潜力,它有望防止PD的进展.
- 安全问题,如瘤性和并发症,需要仔细评估.
- 正在收集临床前和临床数据以确定疗效.
结论:
- 自主干细胞移植是治疗帕金森病的潜在优越方法,与全源移植相比,最大限度地减少了与免疫相关的问题.
- 需要进一步的研究和临床试验,才能充分确定这种方法的安全性和有效性.
- 干细胞疗法在寻求神经退行性疾病 (如PD) 的再生疗法方面取得了重大进展.
相关概念视频
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
Induced Pluripotent Stem Cells
24.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
24.1K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K


